To settle or to move? The interplay between two classes of cyclic lipopeptides in the biocontrol strain Pseudomonas CMR12a by D’aes, J. et al.
To settle or to move? The interplay between two
classes of cyclic lipopeptides in the biocontrol strain
Pseudomonas CMR12a
Jolien D’aes,1 Nam Phuong Kieu,1 Valérie Léclère,2
Caroline Tokarski,3 Feyisara Eyiwumi Olorunleke,1
Katrien De Maeyer,1 Philippe Jacques,2
Monica Höfte1* and Marc Ongena4
1Laboratory of Phytopathology, Faculty of Bioscience
Engineering, Ghent University, Ghent, Belgium.
2ProBioGEM Laboratory UPRES-EA 1026 and
3Miniaturisation pour la Synthèse, l’Analyse & la
Protéomique (MSAP), USR CNRS 3290, and
Protéomique, Modifications Post-traductionnelles et
Glycobiologie, IFR 147, Université de Lille 1-Sciences et
Technologies, Villeneuve d’Ascq Cedex, France.
4Gembloux Agro-Bio Tech, University of Liège,
Gembloux, Belgium.
Summary
Pseudomonas CMR12a is a biocontrol strain that
produces phenazine antibiotics and as yet uncha-
racterized cyclic lipopeptides (CLPs). The CLPs of
CMR12a were studied by chemical structure analysis
and in silico analysis of the gene clusters encoding
the non-ribosomal peptide synthetases responsible
for CLP biosynthesis. CMR12a produces two different
classes of CLPs: orfamides B, D and E, whereby the
latter two represent new derivatives of the orfamide
family, and sessilins A–C. The orfamides are made
up of a 10 amino acid peptide coupled to a β-
hydroxydodecanoyl or β-hydroxytetradecanoyl fatty
acid moiety, and are related to orfamides produced by
biocontrol strain Pseudomonas protegens Pf-5. The
sessilins consist of an 18-amino acid peptide linked
to a β-hydroxyoctanoyl fatty acid and differ in one
amino acid from tolaasins, toxins produced by the
mushroom pathogen Pseudomonas tolaasii. CLP
biosynthesis mutants were constructed and tested
for biofilm formation and swarming motility.
Orfamides appeared indispensable for swarming
while sessilin mutants showed reduced biofilm
formation, but enhanced swarming motility. The
interplay between the two classes of CLPs fine tunes
these processes. The presence of sessilins in wild
type CMR12a interferes with swarming by hampering
the release of orfamides and by co-precipitating
orfamides to form a white line in agar.
Introduction
Cyclic lipopeptides (CLPs) are bacterial metabolites com-
posed of a cyclic oligopeptide coupled to a fatty acid
tail. They are synthesized by non-ribosomal peptide
synthetases (NRPS), encoded on large gene clusters
(Finking and Marahiel, 2004). CLPs are known for their
powerful activity against a wide range of organisms, such
as fungi, bacteria, protozoa and plants (Raaijmakers
et al., 2006; 2010; D’aes et al., 2010). This activity has
been attributed mainly to pore formation and membrane
destabilization as a consequence of their amphiphilic
nature. Bacterial genera capable of CLP synthesis
are quite diverse, including Burkholderia, Lyngbya,
Streptomyces, Bacillus and Pseudomonas spp. Many
studies about CLPs have focused on plant pathogenic
Pseudomonas spp., where they often play a role in
virulence (Scholz-Schroeder et al., 2001; Kunkel and
Zhongying, 2006; Pauwelyn et al., 2013). However,
several plant commensal or beneficial pseudomonads
also produce CLPs, in which case they are involved in a
wide range of natural functions, such as motility
(Andersen et al., 2003), biofilm formation (Roongsawang
et al., 2003; De Bruijn et al., 2008) and even defence
against predation (Mazzola et al., 2009). One main draw
of CLP-producing pseudomonads is their potential as bio-
logical control agents, although in only a few cases it was
proved that the observed biocontrol activity was at least
partly due to the action of CLPs (D’aes et al., 2010).
Pseudomonas CMR12a was isolated from the
rhizosphere of tropical tuber crop cocoyam (Xanthosoma
sagittifolium) in Cameroon. Taxonomically, Pseudomonas
CMR12a belongs to the Pseudomonas fluorescens
complex (Mavrodi et al., 2010), positioned between the
Pseudomonas protegens and Pseudomonas chlororaphis
group (B. Ruffner, M. Péchy-Tarr, M. Höfte, G. Bloemberg,
J. Grunder, C. Keel and M. Maurhofer, in preparation).
The strain has two quorum-sensing systems (De Maeyer
Received 20 October, 2013; revised 14 February, 2014; accepted 15
February, 2014. *For correspondence. E-mail monica.hofte@
ugent.be; Tel. (+32) 9264 60 17; Fax (+32) 9264 62 38.
bs_bs_banner
Environmental Microbiology (2014) doi:10.1111/1462-2920.12462
© 2014 Society for Applied Microbiology and John Wiley & Sons Ltd
et al., 2011) and produces several metabolites, including
phenazines and two different classes of CLPs (De Maeyer
et al., 2013). Phenazines are coloured aromatic
compounds, which are well studied regarding their
biosynthesis, regulation and antibiotic activity (Mavrodi
et al., 2006). Perneel and colleagues (2007) showed that
CMR12a produces two phenazines, namely phenazine-1-
carboxylate and phenazine-1-carboxamide. Concerning
the nature of the CLPs produced by CMR12a however,
only preliminary results were presented to date. D’aes
and colleagues (2011) showed that the first CLP had a
molecular weight of 2028 Da and that for the second CLP
type, three main compounds with molecular ions of 1253,
1279 and 1281 Da were detected. CMR12a is able to
provide protection against several soil-borne diseases,
including root rot on cocoyam and on bean caused
by Pythium myriotylum (Perneel et al., 2007) and
Rhizoctonia solani respectively. In addition, we demon-
strated that phenazines and at least one of the CLPs are
involved in the biocontrol activity of CMR12a against
R. solani (D’aes et al., 2011).
In this work, we performed an in-depth characterization
of the CLPs produced by CMR12a by combining two
approaches, namely genetic analysis of the NRPS genes
responsible for CLP biosynthesis and chemical structure
analysis. Based on data from genome mining, new
biosynthesis mutants were generated to test for a possi-
ble role of these CLPs in crucial functions for rhizosphere
fitness, i.e. motility and biofilm development. These
experiments revealed not only that the two CLPs appear
to play important and differential roles in biofilm formation
and swarming, but also that they may chemically interact
to yield an insoluble form visualized as a white line sur-
rounding colonies.
Results
Structural characterization of the CLPs produced by
Pseudomonas sp. CMR12a
Preliminary analysis of a crude extract by high-
performance liquid chromatography (HPLC)-coupled
electrospray mass spectrometry (LC-ESI-MS) analysis
revealed that CMR12a probably produces at least two
different types of lipopeptides on King’s medium B (KB)
agar, as presented in Fig. 1. These two CLPs were des-
ignated CLP1 and CLP2 originally (D’aes et al., 2011) but
were renamed sessilin and orfamide respectively. For the
sessilin group, one main compound could be detected
(marked as S-A in Fig. 1), which was purified and ana-
lysed in detail. The orfamide cluster showed three plain
peaks (Ofa-B, Ofa-D and Ofa-E in Fig. 1), and all three
compounds were selected for further analysis.
We purified the selected fractions by semi-preparative
reverse phase HPLC, and fractions S-A and Ofa-E were
submitted to quantitative amino acid analysis after total
acid hydrolysis. Fraction S-A contained amino acids Glx,
Ser, Hse, aThr, Val, Ile, Leu, Lys and Pro in a molar ratio
of 2:1:1:1:3–4:1:3:1:1. Two additional minor peaks were
observed in the hydrolysate, which could not be assigned
to an available amino acid standard, and might be attrib-
uted to dhAbu and Dab (see below) (Supporting Informa-
tion Fig. S1). Diode array UV trace in HPLC revealed that
aromatic amino acids, which absorb at 254 nm, are not
present in the peptide backbone. Analysis of fraction
Ofa-E revealed a molar ratio of 1–2:1–2:1:2:4 for Glx, Ser,
aThr, Val and Leu respectively (Supporting Information
Fig. S2).
Further structural identification of the lipopeptides was
performed using high-resolution mass spectrometry.
Nano electrospray ionization Qh Fourier transform ion
cyclotron resonance mass spectrometry (NanoESI-Qh-
FT-ICR MS) analysis of main sessilin fraction S-A showed
the presence of one intense doubly charged ion with
composition C96H168O25N22 (Δm = 1.08 p.p.m.) (Support-
ing Information Fig. S3A, theoretical spectrum shown
in Supporting Information Fig. S3B). The uncharged
Fig. 1. Representative LC-ESI-MS profile of lipopeptides produced
by Pseudomonas CMR12a grown on KB agar medium for 3 days.
Detection was performed in the SCAN mode (total ion counts, m/z
range 900–2040). Molecular masses of the most abundant ion
corresponding to each peak are indicated in the boxed insert.
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molecular formula corresponding to the detected mol-
ecule was C96H166O25N22. A minor doubly charged ion was
also detected on Supporting Information Fig. S3A (theo-
retical spectrum shown in Supporting Information
Fig. S3C), which could be correlated to molecular compo-
sition C96H166O25N22 (Δm = 0.88 p.p.m.; uncharged
molecular formula: C96H164O25N22), pointing to one
unsaturation in the fatty acid moiety.
The exact structure of sessilin A (S-A) (Table 1) was
identified using electron capture dissociation (ECD)
experiments. S-A turned out to be related to tolaasin
(Bassarello et al., 2004), a toxin-like CLP that is produced
by Pseudomonas tolaasii Paine 1919 (type strain NCPPB
2192), the causal agent of brown blotch on cultivated
mushrooms (Nutkins et al., 1991). The CLP is thus made
up of a partially cyclized 18-amino acid peptide chain
coupled to a β-hydroxyoctanoyl fatty acid moiety. As
shown by the generated b+ (b1+, b2+, b4+ to b11+) and z+•
(z5+•, z7+• to z13+•, z15+•, z16+•) fragment ions from the linear
part of the S-A chain (Supporting Information Fig. S4;
Supporting Information Table S1), the difference between
tolaasin and sessilin is due to the sixth amino acid residue
of the peptide chain, which is a serine in tolaasin and a
glutamine in S-A. From accurate m/z ions of S-A and its
fragments (Supporting Information Table S1), and by
analogy with the tolaasin structure (Bassarello et al.,
2004), we could conclude that the cyclized part of the
cycle contains Thr-Ile-Hse-Dab-Lys amino acids linked via
a lactone ring formed between the hydroxyl group of Thr
and the C-terminal part of Lys.
In addition to the main form of tolaasin, tolaasin I, five
other tolaasin derivatives exist that slightly differ with
respect to the nature of the fatty acid chain, the nature of
the amino acid residues at positions 15 and 16 of the
peptide backbone, and the occurrence of an acyclic
derivative (Nutkins et al., 1991; Bassarello et al., 2004).
In the LC-ESI-MS analysis of CMR12a supernatant
extract, we observed at least two additional minor peaks
in the vicinity of the main sessilin compound, which were
marked as sessilin B (S-B) and sessilin C (S-C) in Fig. 1.
S-B presented a doubly charged [M+2H]2+ ion at m/z
1024.2, corresponding to a mass gain of one water mol-
ecule compared with the main compound S-A. This sug-
gested that it may represent an acyclic derivative of S-A,
obtained from hydrolysis of its lactone ring, similar to
tolaasin C. Such a linear structure is supported by the y
ion series yielded upon in source fragmentation (data not
shown). Concerning S-C, a difference of 22 mass units
of the [M+2H]2+ ion compared with that of S-A might cor-
respond to a substitution of Hse16 by glycine, analogous
to Tolaasin II (data not shown). However, the structures
of S-B and S-C remain to be clearly established by
more accurate analyses. Nevertheless, these three com-
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production was concomitantly abolished in the sessilin
mutant of CMR12a (see below) (Supporting Information
Fig. S7), indicating that they are synthesized via the
same NRPS.
High-resolution MS analyses of the orfamide fractions
(Ofa-B, Ofa-D, Ofa-E) resulted in detection of three main
compounds, with molecular formulae C63H112O17N10,
C61H108O17N10 and C63H110O17N10 respectively (data not
shown). ECD experiments for each compound (Support-
ing Information Fig. S5 for fraction Ofa-E) yielded identi-
fication of identical y+ series ions (y8+ and y9+), proving that
the peptide sequence of the three orfamide derivatives is
similar. Identification of a1+, b1+ and b2+ ions confirmed the
presence of Leu and Glu in each derivative linked to a
specific fatty acid chain, i.e. C12:0-OH, C14:1-OH and
C14:0-OH for Ofa-D, Ofa-E and Ofa-B respectively. Addi-
tional b+ ion series that are correlated with the open cycle
resulted in identification of the complete peptide chain, as
shown in Table 1, and Supporting Information Fig. S5 for
Ofa-E (spectra for Ofa-B and Ofa-D not shown). Ions
identified as cyclic Val-Leu-Ser-Leu-Leu-Ser + H+ were
also identified in the ECD spectrum of each orfamide
species. Based on these results, we could conclude that
the structure of the orfamides from Pseudomonas
CMR12a is very similar to that of the previously
characterized lipopeptide produced by the biocontrol
strain P. protegens Pf-5 (Gross et al., 2007). More specifi-
cally, fraction Ofa-B appears to be identical to orfamide B,
and was consequently also named orfamide B. However,
orfamide D (Ofa-D) and orfamide E (Ofa-E) differ from
orfamide A and C by the substitution of allo-Ile4 by a Val
residue, and from orfamide B by modifications of the fatty
acid chain.
In silico analysis of sessilin and orfamide synthetases
Analysis of the CMR12a draft genome revealed two large
NRPS gene clusters that exhibit several typical features of
NRPS genes responsible for CLP biosynthesis, such
as the presence of a starter condensation (C) domain
and two terminal thioesterase domains (Fig. 2). These
sequence data have been submitted to the GenBank
databases under accession number JQ309920 and
JQ309921 for the NRPS gene clusters and flanking
regions of sessilin and orfamide respectively. In each
NRPS gene cluster, three large open reading frames
(ORFs) could be identified, together spanning a region of
60189 and 34453 base pairs respectively.
Fig. 2. Putative NRPS gene clusters identified in the genome of CMR12a by in silico analysis. A description of flanking gene similarity and
putative function can be found in Table 2.
A. Gene cluster composed of three NRPS-encoding ORFs, designated sesA, sesB and sesC, responsible for sessilin biosynthesis in CMR12a.
B. Gene cluster composed of three NRPS-encoding ORFs, designated ofaA, ofaB and ofaC, responsible for orfamide biosynthesis in
CMR12a. Arrows represent ORFs encoding separate NRPSs in each gene cluster. Positions and nature of sessilin and orfamide biosynthesis
mutations are indicated. M, module responsible for addition of one amino acid to peptide chain; Te, thioesterification domain. Predicted amino
acid specificity, including putative absolute configuration, is shown under each A domain. dhAbu, 2,3-dehydro-2-aminobutyric acid; Thr,
threonine; Pro, proline; Ser, serine; Leu, leucine; Asp, asparagine; Val, valine; Gln, glutamine; Ile, isoleucine; Dab, 2,4-diaminobutyric acid;
Lys, lysine.
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The largest gene cluster (Fig. 2A) contains three NRPS
genes sesA, sesB and sesC, which each encode six
modules, consisting of a C or dual C/epimerization (C/E)
domain (see below), adenylation (A) and thiolation (T)
domain. At the amino acid level, these genes are related
to the syringopeptin encoding genes from Pseudomonas
syringae pv. syringae (Scholz-Schroeder et al., 2003)
(Table 2). Moreover, they show very high similarity with
hypothetical genes from P. tolaasii (Table 2), which may
suggest that these hypothetical genes code for tolaasins.
The translated sequences of each ORF were studied with
online NRPS specificity prediction software, which analy-
ses the A domains, and by phylogenetic analysis of their C
domains (see next section). Globally, putative peptide
sequences obtained this way are in agreement with
the structure derived by chemical analysis of sessilin.
However, several ambiguities remained because predic-
tion for module 15 was only indicative of a non-polar
monomer, and no reliable prediction could be acquired for
module 16, which is in agreement with the chemical
analysis that showed a putative relaxed substrate selec-
tivity of module 16, resulting in Hse16 in S-A and Gly16 in
S-C. We assumed that the second NRPS gene cluster
(Fig. 2B) encoded the synthetases responsible for
orfamide production. This cluster is also composed of
three NRPS genes, designated ofaA, ofaB and ofaC.
However, they are considerably smaller, containing two,
four and again four C-A-T modules respectively. At the
amino acid level, these genes show high similarity with
the orfamide encoding genes ofaA (PFL2145), ofaB
(PFL2146) and ofaC (PFL2147) from P. protegens Pf-5
(Table 2). The predicted peptide chain consists of 10
amino acids and agrees with the results of the chemical
structure analysis of orfamide. Interestingly, the in silico
sequence analysis confirmed that module 4 of the
synthetases favours the incorporation of a Val residue in
Table 2. Predicted ORF in biosynthesis gene clusters and flanking areas of sessilin and orfamide.
Putative function
Similarity
P. protegens Pf-5 P. syringae pv. syringae B728a P. tolaasii PMS117
Sessilin biosynthesis cluster and flanking area
1 NodT family efflux transporter outer
membrane factor lipoprotein
71% PFL_2142 71% Psyr_2606 97% multidrug transporter
WP_016969116.1
2 LuxR family transcriptional regulator 56% PFL_2143 49% Psyr_2607 94% hypothetical protein
WP_016969117.1
3 Cyclic peptide transporter 70% Psyr_2613 (syrD) 98% ATP binding protein
WP_016969118.1
sesA Non-ribosomal peptide synthetase 58% Psyr_2614 (sypA) 97% hypothetical protein, partial
WP_016969119.1
sesB Non-ribosomal peptide synthetase 58% Psyr_2615 (sypB) 96% hypothetical protein, partial
WP_016968894.1a
sesC Non-ribosomal peptide synthetase 57% Psyr_2616 (sypC) 97% hypothetical protein, partial
WP_017255869.1a
4 Macrolide efflux protein MacA 81% PFL_2148 72% Psyr_2617 97% hemolysin secretion
protein D WP_016971832.1
5 Macrolide efflux protein MacB
diaminobutyrate-2-oxoglutarate
transaminase/diadenosine
80% PFL_2149 77% Psyr_2618 99% macrolide ABC transporter
ATP binding protein
WP_016971833.1
6 Tetraphosphate 76% Psyr_2619 98% diadenosine
tetraphophatase
WP_016971834.1
Orfamide biosynthesis cluster and flanking area
1 Putative (protein) acetyltransferase 50% Brevibacillus
sp. BC25
2 LuxR family transcriptional regulator 78% PFL_2143
ofaA-12a Non-ribosomal peptide synthetase 79% PFL_2145 (ofaA)
ofaB-12a Non-ribosomal peptide synthetase 82% PFL_2146 (ofaB)
ofaC-12a Non-ribosomal peptide synthetase 82% PFL_2147 (ofaC)
3 Macrolide efflux protein MacA 92% PFL_2148
4 Macrolide efflux protein MacB 91% PFL_2149
5 LuxR family transcriptional regulator 74% PFL_2150
6 Glyoxalase family protein 79% PFL_2151
7 Heme transporter CcmD, radical
SAM domain protein
93% PFL_2152
a. From P. tolaasii 6264.
Annotation was derived from BLAST analysis. Percentage of sequence identity at the amino acid level to the most related genes (based on max
score) is shown.
ABC, ATP binding cassette; ATP, adenosine tri-phosphate; Syp, syringopeptin synthetase.
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the peptide, while for orfamide from P. protegens Pf-5, the
prediction indicated that an Ile is preferably selected by
this module (Gross et al., 2007). Indeed, HPLC analysis
of the acid hydrolysate of orfamide E (Supporting Infor-
mation Fig. S2) detected the presence of Val, but not of Ile
and in the ECD spectrum the Val residue in the peptide
sequence was localized using the b4+ fragment ion (Sup-
porting Information Fig. S5).
Phylogenetic analysis of C domains to predict putative
absolute configuration
Because no separate E domains were detected in the
synthetases for sessilin and orfamide, we assumed that
the incorporation of D-amino acids probably occurs
through the action of dual C/E domains, as was described
before for CLP synthetases in other pseudomonads
(Balibar et al., 2005; De Bruijn et al., 2008; Dubern et al.,
2008). It was shown that these dual C/E domains can be
distinguished from ordinary C domains by the presence of
specific signature sequences. Therefore, we constructed
a phylogenetic tree starting from 91 sequences corre-
sponding to the C domains of 7 CLPs, including 28
sequences implicated in C activity of sessilin and
orfamide synthetases (Supporting Information Fig. S6).
The phylogenetic analysis is detailed in the supplemen-
tary data and points to a putative structure for sessilin with
the same absolute configuration as that of tolaasin, while
the prediction of the absolute configuration for orfamide of
CMR12a is presumably the same as for orfamide of
P. protegens Pf-5 (Table 1).
Flanking regions of sessilin and orfamide synthetases
Overall, flanking regions of the biosynthesis gene clusters
for sessilin and orfamide (Fig. 2 and Table 2) are similar to
the ones found in the vicinity of CLP biosynthesis genes
in other strains and include both putative regulator and
transporter genes. In particular, the genes flanking
ofaABC in Pseudomonas CMR12a are quite well con-
served in comparison with the ones flanking the orfamide
biosynthesis genes in P. protegens Pf-5. However,
in P. protegens Pf-5, a LuxR-type regulator gene
(PFL_2143) upstream of the biosynthesis genes is pre-
ceded by a gene encoding a NodT family efflux trans-
porter outer membrane factor lipoprotein (PFL_2142),
while in CMR12a, this gene is lacking. Instead, genes
showing moderate sequence similarity to unrelated
species, i.e. Brevibacillus, Xenorhabdus and Neisseria
spp., were found upstream of the LuxR-type regulator
gene. Whether these genes are connected with orfamide
synthesis was not determined. The flanking genes of
sesABC are analogous to the genes found in the vicinity
of the syringomycin–syringopeptin biosynthesis clusters
of P. syringae, although some of the genes, especially
macA and macB, bear a higher similarity to their ana-
logues in P. protegens Pf-5. Interestingly, the whole gene
cluster shows very high sequence similarity with hypo-
thetical genes of the mushroom pathogen P. tolaasii
(Table 2) and with whole genome shotgun contigs of the
mushroom pathogens P. fluorescens NZI7 (contig 00085,
00090 and 00096 in GenBank), P. tolaasii PMS117
(contigs 00008, 00011, 00029, 00123 in GenBank),
P. tolaasii NCPPB2192 (SCF_14836_01357 and SCF_
14836_03198 in GenBank) and P. tolaasii 6264 (contigs
00166, 00245, 00275 and 00828 in GenBank). The
upstream region of the sessilin gene cluster contains
various integrases and transposases indicating that the
cluster is on a chromosomal island and probably obtained
by horizontal gene transfer.
Characterization of phenazine, sessilin and orfamide
biosynthesis mutants
Mutants in phenazine production and/or sessilin synthesis
were already available (Supporting Information Table S3)
(D’aes et al., 2011). The knowledge acquired in this
study about the biosynthesis genes for orfamide allowed
for the construction of biosynthesis mutants in this CLP. To
investigate the importance of phenazines and CLPs for
biofilm formation and swarming by CMR12a, four new
site-specific mutants in CLP and/or phenazine bio-
synthesis were created, i.e. an orfamide biosynthesis
mutant CMR12a-ΔClp2, a double phenazine and
orfamide mutant CMR12a-ΔPhz-ΔClp2, a double sessilin
and orfamide biosynthesis mutant CMR12a-ΔClp2-Clp1,
and CMR12a-ΔPhz-ΔClp2-Clp1, in which production of all
three metabolites was knocked out. LC-ESI-MS analysis
of culture extracts confirmed that production of orfamide
B, D and E by CMR12a-ΔClp2 and CMR12a-ΔPhz-ΔClp2
was completely abolished. Mutants CMR12a-ΔCLP2-
Clp1 and CMR12a-ΔPhz-ΔClp2-Clp1 produced neither
sessilin nor orfamide (Supporting Information Fig. S7). In
addition, HPLC on culture extracts (results not shown)
confirmed that all mutants with a deletion in the phenazine
biosynthesis operon no longer produced any phenazines.
We demonstrated before that the sessilin mutant
CMR12a-Clp1 makes markedly more phenazines than
the wild type (D’aes et al., 2011), although at this point we
can only speculate about the mechanism involved in this
phenomenon. Overproduction of phenazines was not
observed for the other biosynthesis mutants (data not
shown). We did not observe noticeable growth defects
(based on optical density measurements and growth rate)
on complex media such as Luria–Bertani (LB) or KB
broth or defined media such as M9 mineral medium with
different carbon sources caused by the mutations in
phenazine, sessilin or orfamide production (data not
6 J. D’aes et al.
© 2014 Society for Applied Microbiology and John Wiley & Sons Ltd, Environmental Microbiology
shown), indicating that these metabolites have no marked
role for primary metabolism in vitro.
Swarming by CMR12a requires orfamide
The importance of sessilin and orfamide for swarming was
investigated via surface motility assays on standard
succinate medium (SSM) and modified LB (MLB) medium
with low agar content (0.6% agar) (Fig. 3).
The wild type CMR12a did not exhibit swarming on
SSM (Fig. 3A), although this medium was used to dem-
onstrate swarming by other Pseudomonas strains, such
as P. fluorescens SS101 (De Bruijn et al., 2008). On MLB
medium, moderate swarming of the wild-type strain
Pseudomonas CMR12a started after 24 h (Fig. 3B) and
was more noticeable at 48 h (Supporting Information
Fig. S8). However, sessilin biosynthesis mutants showed
swarming on both media. Orfamide production is required
for the swarming ability of CMR12a because swarming
was completely abolished on both media in all orfamide
biosynthesis mutants.
LC-ESI-MS analysis revealed the presence of both
CLPs in wild-type cells grown on MLB medium or SSM,
indicating that the inability to swarm is not due to the
absence of orfamide (Fig. 3C and D). These analyses
also showed that the improved swarming of the CMR12a-
Clp1 mutant does obviously not result from a higher pro-
duction of orfamide compared with wild-type cells (Fig. 3C
and D). For complementation assays, mutant strains were
co-cultured with the wild-type strain or with each other on
SSM and MLB medium. Remarkably, swarming of the
sessilin mutant CMR12a-Clp1 was abolished in the pres-
ence of the wild-type (B + A in Fig. 3) or CMR12a-ΔClp2
mutant (B + C in Fig. 3). LC-ESI-MS analysis revealed
that under these conditions, orfamides are still produced
(Fig. 3C and D). Moreover, the orfamide-deficient mutants
CMR12a-ΔClp2 and CMR12a-ΔClp2-Clp1 double mutant
could be complemented for swarming by supplying a
semi-purified orfamide extract or orfamide-containing
supernatant from CMR12a-Clp1 to MLB medium (Sup-
porting Information Figs S8 and S9). Sessilin-containing
supernatant from the CMR12a-ΔClp2 mutant slightly
diminished swarming of the wild type on MLB medium, but
was unable to stop swarming of the CMR12a-Clp1 mutant
(Supporting Information Fig. S9).
Sessilin but not orfamide is involved in biofilm formation
by CMR12a
Biofilm formation by CMR12a and its mutants was tested
in polystyrene 96-well plates filled with AB broth amended
with 2% casamino acids, similar to a method described by
Maddula and colleagues (2006). With this set-up,
CMR12a forms biofilms at the interface between air and
liquid. Figure 4A displays the development of biofilms by
CMR12a and its mutants. Growth speed and maximal cell
densities were comparable with that of the wild-type strain
for all the mutants under these conditions. Remarkably,
sessilin mutants formed markedly less biofilm in the
plates. Phenazines appeared to play a limited role in
biofilm formation by CMR12a, while the mutant in
orfamide biosynthesis (CMR12a-ΔClp2) produced more
biofilm than the wild type. Interestingly, mutations were
able to (partially) compensate each other if causing con-
trasting effects. For example, the amount of biofilm
formed by CMR12a-ΔClp2-Clp1 was intermediary
between that of the wild type and CMR12a-Clp1.
LC-ESI-MS profiling of the lipopeptides produced by the
wild type under biofilm-forming conditions revealed an
efficient production of sessilins (Fig. 4B). However, no
orfamide could be detected in the culture filtrate (below
detection limit). When grown in the same medium but in
agitated flask cultures, CMR12a formed more biomass
(data not shown), but cells remained planktonic and pro-
duction of sessilin was clearly reduced compared with
biofilm-forming conditions as illustrated in Fig. 4B.
Sessilin and orfamide interact to form a white
line precipitate
Sessilin is related to tolaasin, produced by the mushroom
pathogen P. tolaasii. Since it is known that tolaasin can
co-precipitate with white line-inducing principle (WLIP)
(Wong and Preece, 1979), a viscosin-related CLP pro-
duced by Pseudomonas ‘reactans’ NCPPB 387 we tested
the ability of sessilin to form a white-line-in-agar reaction
with WLIP and other CLPs. In the experiment depicted in
Fig. 5, which was performed on KB agar medium, the
CMR12a strain and its three CLP mutants were con-
fronted to each other and to four other Pseudomonas
isolates with specific CLP signatures. These experiments
revealed that the wild-type strain Pseudomonas CMR12a
(1) shows a white-line-in-agar reaction with mutant
CMR12a-Clp1 (2), which only produces orfamides, but
not with the mutant CMR12a-ΔClp2 (3), which only
produces sessilins, or mutant CMR12a-ΔClp2-Clp1 (4),
which does not produce CLPs. Mutant CMR12a-Clp1 (2),
however, forms a white line reaction with CMR12a (1) and
mutant CMR12a-ΔClp2 (3). The tolaasin-producing mush-
room pathogen P. tolaasii (5), forms a white-line-in-agar
with WLIP produced by P. ‘reactans’ NCPPB 387 (6),
and this is also the case for the sessilin producers
Pseudomonas CMR12a (1) and CMR12a-ΔClp2 (3).
Moreover, a clear white line reaction was also observed
between sessilin producers and the orfamide-producing
strain P. protegens Pf-5 (7), but not with the massetolide
producing strain P. fluorescens R1SS101 (8). From these
experiments, it can be concluded that, although the
Cyclic lipopeptides of Pseudomonas CMR12a 7
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wild-type strain Pseudomonas CMR12a produces both
sessilins and orfamides on KB medium (see Fig. 1), only
sessilin is released in the KB agar medium, while
orfamides are either not secreted or retained close to the
cell wall. The sessilin mutant CMR12a-Clp1, however,
readily releases orfamides in the medium. Matrix assisted
laser desorption/ionisation time-of-flight mass spectrom-
etry (MALDI-ToF MS) analysis of lipopeptides present in
KB agar medium during interaction between CMR12a-
ΔCLP2 and CMR12a-CLP1 confirmed that both orfamide
and sessilin accumulate in the zone corresponding to the
white line, strongly suggesting that the two compounds
interact to form a precipitate (see Supporting Information
Fig. S10 for details).
Discussion
Pseudomonas CMR12a produces two different classes
of CLPs
Our study revealed that Pseudomonas CMR12a pro-
duces two different classes of CLPs, which display spe-
cific structural features but are related to previously
described CLPs, namely tolaasins and orfamides.
Fig. 4. A. Biofilm formation capacity of CMR12a and its phenazine and CLP mutants. The y-axis represents the surface under the curve
obtained for measurements in time of crystal violet solutions at 595 nm, which are directly proportional to development of biofilms.
Experiments were repeated at least once, and each time 11 replicates per treatment were used. Means of two experiments are shown.
Different letters indicate significantly different treatments (α = 0.05). Vertical bars indicate standard deviations. ΔPhz, phenazine biosynthesis
mutant; CLP1, sessilin biosynthesis mutant; ΔCLP2, orfamide biosynthesis mutant.
B. LC-ESI-MS chromatogram showing sessilin production by CMR12a in AB + casamino acids medium. a, biofilm forming cells in liquid
medium (in 96-well plates); b, planktonic cells in liquid medium (agitated flask cultures).
Fig. 5. White-line formation obtained by
confronting various CLP producing
Pseudomonas strains on KB medium. Picture
was taken after 6 days incubation at 28°C.
Strains used: (1) Pseudomonas sp. CMR12a;
(2) CMR12a-Clp1; (3) CMR12a-ΔClp2; (4)
CMR12a-ΔClp2-Clp1; (5) P. tolaasii NCPPB
2192; (6) P. ‘reactans’ NCPPB 387; (7)
P. protegens Pf-5; (8) P. fluorescens
R1SS101. See Supporting Information
Table S3 for strain characteristics.
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The first class of CLPs secreted by CMR12a, which
were designated sessilins, can be classified in the
tolaasin group of Pseudomonas lipopeptides. Tolaasins
are produced by mushroom pathogens such as
P. tolaasii and P. fluorescens NZI7 (Burlinson et al.,
2013). But this group also contains fuscopeptin and
corpeptin isolated from plant pathogenic pseudomonads
(Gross and Loper, 2009). In fact, the main sessilin
derivative from CMR12a differs only by one amino acid
from tolaasin I, the most abundant form of tolaasin
(Bassarello et al., 2004). Our analysis indicated that
CMR12a also produces a putative acyclic derivative of
sessilin, designated S-B, together with a third form in
which Hse16 is replaced by a Gly residue, and which
was named S-C. The presence of these derivatives
might explain the ambiguous results obtained by in silico
analysis of the sessilin biosynthesis genes. Indeed, the
specificity of modules 15 and 16 could not be predicted,
probably because they might be somewhat flexible
towards the nature of the amino acid residues they can
bind. It also seems clear that S-A is the preferred deriva-
tive synthesized by CMR12a. However, it is possible that
culture and environmental conditions influence the ratio
of the different derivatives produced. The tolaasin-
encoding genes of P. tolaasii and P. fluorescens NZI7
have not been annotated, but the sessilin biosynthetic
genes and surrounding genes show very high similarity
(about 94% at the nucleotide level) with hypothetical
genes on whole genome shotgun contigs of P. tolaasii
(various strains) and P. fluorescens NZI7 (Burlinson
et al., 2013). It indicates that these genes most likely
are responsible for tolaasin biosynthesis and secre-
tion. This high level of similarity is striking because
Pseudomonas CMR12a and P. tolaasii are relatively dis-
tantly related with a level of similarity for housekeeping
genes such as gyrB, rpoB and recA around 88–91%.
The presence of transposases and integrases upstream
of the sessilin gene cluster indicates that these genes
are located on a genomic island that Pseudomonas
CMR12a has acquired by horizontal gene transfer
(Juhas et al., 2009).
The second group of CLPs produced by CMR12a were
identified as very similar to orfamide produced by the
biocontrol strain P. protegens Pf-5 (Gross et al., 2007).
These three orfamide derivatives were analysed structur-
ally, which were designated orfamide B, D and E respec-
tively. However, they still differ from orfamides regarding
the fatty acid chain length and saturation, and by the
absence of an Ile4 residue in the peptide backbone. The
identity at amino acid level between both orfamide
biosynthesis gene clusters is only around 80%, while
at nucleotide level the similarity varies from 80% to
84% identity. This similarity is rather low because
Pseudomonas CMR12a and P. protegens Pf-5 are closely
related, and their housekeeping genes such as rpoB, gyrB
and recA show a similarity of 92–94%. Moreover, results
from in silico prediction of the amino acid residues show
that the fourth module in the orfamide synthetase from
Pf-5 activates an isoleucine residue instead of a valine
residue in orfamide from Pseudomonas CMR12a, indicat-
ing that the catalytic domains differ significantly at
this site.
CLPs are secreted by ABC transporters similar to
the Echerichia coli macrolide efflux transporter MacA-
MacB-TolC. Genes potentially involved in orfamide
secretion (MacA and MacB) and regulation (LuxR
regulators) are found downstream of the orfamide
biosynthetic genes and are conserved at the amino acid
level between Pf-5 and CMR12a. The TolC equivalent
is presumably encoded by the Pfl_2142 gene in
P. protegens Pf-5. It is annotated as a NodT family efflux
transporter and precedes the gene encoding the LuxR
transcriptional regulator upstream of the orfamide
biosynthesis genes in Pf-5. This genomic organization of
transporter genes is similar in various Pseudomonas
CLP gene clusters (De Bruijn et al., 2008; Dubern
et al., 2008; Vallet-Gely et al., 2010; Rokni-Zadeh
et al., 2012; Li et al., 2013). However, the involvement
of the putative NodT efflux transporter in CLP efflux has
to our knowledge not been experimentally shown. Inter-
estingly, there is no homologue of Pfl_2142 in the
orfamide gene cluster of Pseudomonas CMR12a, but its
closest homologue in the Pseudomonas CMR12a
genome is found upstream of the sessilin gene cluster
(Table 2).
So far, simultaneous production of two different
classes of CLPs by one strain has only been demon-
strated for plant-pathogenic pseudomonads. The reason
for this phenomenon is not clear, but several authors
have already suggested that in these cases one CLP
could have surfactant-like activity, while the other CLP
would be rather toxin-like, resulting in a synergistic
effect with increased virulence towards the host plant
(Iacobellis et al., 1992; Batoko et al., 1998; Bender et al.,
1999). However, our strain clearly displays plant-
beneficial properties, implying a different biological role
for its CLPs as compared with plant-pathogenic species.
Sessilin is implicated in the biocontrol of R. solani and
other fungal pathogens and strongly inhibits their growth
in vitro (D’aes et al., 2011). Pure tolaasin I, produced
by P. tolaasii NCPPB2192, inhibits the growth of edible
fungi such as Agaricus bisporus, Lentinus edodes and
Pleurotus spp. (Lo Cantore et al., 2006). These results
indicate that both P. tolaasii and biocontrol agents such
as Pseudomonas spp. CMR12a can be considered as
fungal pathogens. It would be worthwhile to investigate
whether tolaasin-producing mushroom pathogens such
as P. tolaasii and P. fluorescens NZI7 also produce a
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second CLP and whether they have biocontrol activities
when applied to plant roots. In this context, it is notewor-
thy that the genome of P. fluorescens NZI7 is very similar
to that of the biocontrol agent P. protegens Pf-5
(Burlinson et al., 2013).
Sessilins and orfamides are differentially involved in
biofilm formation and swarming
The fact that CMR12a produces at least two CLPs as well
as two phenazine derivatives must imply a particularly
important role for these molecules in the survival of
CMR12a in its natural niche. Biosynthesis mutants in
phenazines, sessilin and/or orfamide were shown to grow
adequately in vitro. However, in a natural environment,
bacterial cells typically exist as biofilm communities. In
addition, the ability to migrate on a surface provides an
advantage in order to locate new nutrient-rich habitats
(Verstraeten et al., 2008). Some studies already demon-
strated that CLPs are of essential importance for the
formation of biofilms and for swarming motility
(Raaijmakers et al., 2010). Here, we showed that a
sessilin mutation caused a drastically reduced capacity
for biofilm formation on a hydrophobic surface, while
orfamide biosynthesis mutants showed increased biofilm
formation, indicating that sessilins are crucial for biofilm
formation in Pseudomonas CMR12a. Phenazines have
been shown to influence biofilm formation as well
(Maddula et al., 2006; 2008; Ramos et al., 2010; Selin
et al., 2010), but these compounds have only a limited
(albeit significant) influence on biofilm formation by
CMR12a. This effect is actually much less pronounced
than for P. chlororaphis 30–84, in which case biofilm for-
mation capacity is strongly reduced in a phenazine
biosynthesis mutant (Maddula et al., 2006).
Orfamide biosynthesis mutants completely lost their
swarming ability, which could be restored by adding a
crude orfamide extract to the swarming plates. These
data confirm the observations of Gross and colleagues
(2007), showing that orfamide is also required for
swarming by P. protegens Pf-5. Other CLPs with activity
similar to that of orfamide have already been character-
ized, for example putisolvin and arthrofactin, produced
by P. putida PCL1445 and Pseudomonas sp. MIS38
respectively (Roongsawang et al., 2003; Kuiper et al.,
2004).
A remarkable result of the swarming assays was the
inability of CMR12a to swarm on SSM and the retarded
swarming on MLB medium, which is not due to the
absence of orfamides, because the molecules could
readily be detected in cells grown on these two media.
Unlike the wild type, the sessilin biosynthesis mutant
CMR12a-CLP1 was no longer prevented from swarming
on these media.
The interplay between sessilins and orfamides
determines whether Pseudomonas CMR12a cells settle
or move
Our data suggest that the presence of sessilin interferes
with swarming activity in two different ways. As has been
shown before for tolaasins and WLIP (Wong and Preece,
1979), sessilins and orfamides chemically interact and
co-precipitate with each other to form a white line in agar.
In addition, the white line assays suggest that the pres-
ence of sessilin in Pseudomonas CMR12a interferes with
the release of orfamides in the medium.
It is interesting to notice that tolaasins and sessilins not
only form a white line with WLIP, a CLP belonging to the
viscosin group (Rokni-Zadeh et al., 2013), but also with
orfamides. The white line reaction was thought to be
structure specific for WLIP and strains able to produce
WLIP used to be grouped as P. ‘reactans’ and are com-
monly used in diagnostic tests to identify tolaasin produc-
ers. Rokni-Zadeh and colleagues (2013), however,
recently showed that various P. fluorescens and P. putida
strains are able to produce WLIP, urging the discontinua-
tion of the use of the invalid species designation
P. ‘reactans’. Intriguingly, not only WLIP, but also
orfamides trigger the white line reaction with tolaasins and
sessilins, while CLPs which are more closely related to
WLIP such as viscosin (Rokni-Zadeh et al., 2013) and
massetolide (Table 1) do not trigger such reaction. This
definitely warrants further investigation. The interaction
between the two CLPs probably explains why in the com-
plementation assays on swarming medium, the swarming
of sessilin mutants can be blocked by sessilin producers
such as the wild-type strain or orfamide mutants. It should
be noted, however, that we were unable to block the
motility of the sessilin mutants by adding sessilin-
containing supernatant from mutant CMR12a-Clp2.
The white line assays revealed that release of orfamide
in the environment is hampered in the presence of
sessilins, either because orfamide is retained within the
cytoplasm or periplasm or stays closely associated with
the cell surface. In this context, it is interesting to recall
that the orfamide gene cluster in Pseudomonas CMR12a
is not preceded by a NodT family efflux transporter. One
possible explanation could be that the MacA-MacB trans-
porters of sessilin and orfamide make use of the same
outer membrane efflux transporter upstream of the
sessilin biosynthetic cluster. Further investigation is
needed to find out whether competition for the outer mem-
brane protein could explain the negative effect of sessilin
on orfamide secretion. We speculate at this point that
sessilin might act as a signal molecule involved in fine
tuning the balance between biofilm formation and surface
motility in response to environmental cues. Such cues
could be nutrient limitation or stress conditions, but this
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requires further study. It is not unlikely that CLPs act as
signal molecules. A study by López and colleagues (2009)
pointed to a regulatory role for surfactin, a CLP produced
by Bacillus subtilis, in biofilm formation. Apparently,
surfactin influenced the activity of ion channels, causing
potassium leakage from the cytoplasm. Potassium
leakage stimulated the activity of a membrane protein
kinase, which governed the expression of genes involved
in biofilm formation. As tolaasin has been described to
form cation-selective ion channels in planar lipid bilayer
(Brodey et al., 1991), such a mechanism could be evoked
to explain the role of sessilin in biofilm formation.
The question remains why sessilins and orfamides
exhibit such divergent biological activity. Raaijmakers and
colleagues (2010) discuss the influence on biofilm forma-
tion of hydrophobicity and charge of the lipopeptide, its
orientation towards the bacterial cells, as well as environ-
mental conditions. Furthermore, the length of the fatty
acid chain and composition of the peptide moiety can be
a crucial determinant of CLP activity (Morikawa et al.,
2000; Jourdan et al., 2009). This might explain some of
the differences between both metabolites as sessilins
harbour a rather short (C8) and orfamides a long (C12 or
C14) fatty acid moiety.
Regulation of CLP production in
Pseudomonas CMR12a
Presently, little information is available about regulation of
sessilin and orfamide production by CMR12a. We know
that the GacS/GacA two-component system controls syn-
thesis of both CLPs (D’aes et al., 2011). Inspection of the
flanking regions of sessilin and orfamide synthetase
genes revealed several LuxR-type regulator genes, which
are typically found in the vicinity of CLP biosynthesis gene
clusters. In other Pseudomonas strains, these LuxR-type
proteins are involved in regulation of CLP production (De
Bruijn and Raaijmakers, 2009); thus, it might be assumed
that they fulfil a similar role in the regulation of orfamide
and sessilin synthesis. This, however, needs further
investigation. The two quorum-sensing systems of
Pseudomonas CMR12a also appear to be involved in
CLP regulation, albeit in an indirect way (N. P. Kieu,
unpubl. data).
Pseudomonas CLPs and biocontrol
With regard to the multifunctionality of phenazines and
CLPs in other strains, it is likely that these metabolites
still have other parts to play in the cell physiology of
CMR12a. Previously, we proved that sessilin is involved
in biocontrol of root rot on bean caused by R. solani,
presumably because of its direct antimicrobial activity.
We showed that sessilin strongly suppresses R. solani
growth, and microscopic observations revealed that
CMR12a causes branching of R. solani mycelium, while
a sessilin biosynthesis mutant loses this ability (D’aes
et al., 2011). In vitro assays with biosynthesis mutants
indicated that sessilin also inhibits growth of other patho-
gens, for example P. myriotylum, Pythium splendens and
Fusarium oxysporum f. sp. lycopersici (unpublished).
Furthermore, preliminary experiments suggest that
sessilin induces dark-brown lesions on mushrooms (data
not shown), similar to the effects ascribed to tolaasin
(Hutchison and Johnstone, 1993). The results described
in this paper shed new light on the biological activity of
sessilin by pointing to an important role in maintaining a
balance between biofilm formation and motility. This bio-
logical role might also explain part of the importance of
sessilin for the biocontrol ability of CMR12a because
establishment of a rhizosphere population is a prerequi-
site for biocontrol agents (Dutta and Podile, 2010).
However, to further elucidate the mechanisms involved
in the biological activity of sessilin, much more work will
be necessary.
The significance of orfamides for the biocontrol prop-
erties of CMR12a is still being investigated at present.
Preliminary data suggest that the direct antagonistic
properties of orfamides are not as pronounced as those
of sessilin, but that orfamides are essential for biocontrol
activity in vivo (data not shown). It is likely that its
observed role in swarming will also affect the
rhizosphere competence of CMR12a. However, it is not
sure how effects of phenazines and CLPs on biofilm for-
mation and swarming observed in vitro can be extrapo-
lated to root colonization. Barahona and colleagues
(2010) showed that P. fluorescens mutants deficient for
biofilm formation on abiotic surfaces colonized alfalfa
roots as efficiently as the wild-type strain. Our results
(D’aes et al., 2011) indicated that phenazine, sessilin and
orfamide mutants can still colonize roots, but the obser-
vations were based on short-term colonization experi-
ments and were not always consistent. More in-depth
study will be required to assess whether orfamides for
instance could be involved in spreading of the bacteria to
more distal parts of the roots, while sessilin and/or
phenazines could be required to maintain developed
microcolonies on the root surface for longer periods.
Experimental procedures
Strains and culture conditions
Strains, plasmids and primers used in this study are listed in
Supporting Information Table S3. Pseudomonas sp. CMR12a
was grown on KB (King et al., 1954) at 28°C. Echerichia coli
strains were cultivated on LB medium (Sambrook et al.,
1989) at 37°C, and Saccharomyces cerevisiae InvSc1 at
30°C on yeast extract-peptone-dextrose (Shanks et al.,
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2006). When required, gentamicin was added at a concen-
tration of 25 μg ml−1 for E. coli strains and at 300 μg ml−1 for
Pseudomonas CMR12a and mutant strains.
Analysis of CLPs by LC-ESI-MS
Crude extracts were prepared by collecting cells from fully
covered KB plates in distilled water, followed by centrifuga-
tion, filter sterilization of the supernatant and concentration
by lyophilization if required. To screen for high molecular
weight compounds potentially representing CLPs, the
extracts were analysed by reverse-phase LC-ESI-MS
(HPLC Waters Alliance 2695/diode array detector, coupled
with Waters SQD mass spectrometer) on an X-terra MS C18
column (100*4.6 mm, 3.5 μm, Waters), as described before
(D’aes et al., 2011). For structural analysis of CLPs by
LC-ESI-MS, HPLC purified samples (see below) were
injected under the same HPLC conditions, but MS settings
used to optimize in-source fragmentation were as follows:
positive ion mode, source temperature of 130°C, desolvation
temperature of 280°C, nitrogen flow of 550 l h−1 and cone
voltage of 100 V.
Purification of CLPs by semi-preparative HPLC
For purification of the CLP-containing fractions, the crude
extract was subjected to repeated injections with an Agilent
1100 series HPLC (Hewlett Packard) on a VYDAC® C18
reversed-phase 218TP5 column suitable for separation
of small polypeptides less than 4000–5000 MW (5 μm,
4.6 mm × 250 mm). Metabolites were eluted with a gradient
of acetonitrile (ACN) acidified with 0.1% formic acid (eluent
B) in water acidified with 0.1% formic acid (eluent A) at a
constant flow rate of 1 ml min−1 and at room temperature.
The gradient programme lasted 45 min, starting at 30% B
during 5 min, rising to 51% B in 5 min, further to 65% B in
the following 10 min and on to 70% during a 12 min step.
Eluent B was kept at 70% during 5 min, lowered again to
30% over 0.5 min and equilibrated during 7.5 min. The
UV signal was monitored at 220 nm. All different fractions
were collected and concentrated using rotavaporation and
vacuum speed.
Quantitative amino acid analysis
For amino acid analysis, HPLC-purified compounds were
collected in glass tubes and dried using vacuum speed
(Speed-Vac Plus SC110A; Savant). One and a half millilitres
of 6 N HCl was added to the glass tubes, which were subse-
quently sealed under vacuum. Samples were hydrolysed at
115°C during 6 h. After drying in the Speed-Vac, and dissolv-
ing in 100 μl of 0.1 N HCl, the samples were analysed on a
ZORBAX Eclipse AAA column (Agilent) using a Agilent 1100
series HPLC (Hewlett Packard) by strictly following the
instructions provided by the Agilent manufacturer. Briefly,
the hydrolysed samples and amino acid standard solutions
were automatically derivatized in the autosampler with
o-phthalaldehyde (OPA) for most amino acids and 9-
fluorenylmethyl-chloroformate (FMOC) for lysine, hydroxy-
proline and proline residues. After derivatization, 0.5 μl of
each sample was injected with a flow rate of 2 ml min−1 and
detected at 338 nm (OPA) and 262 nm (FMOC). Solution A
was 40 mM NaH2PO4, adjusted to pH 7.8 with NaOH, while
solution B was ACN/methanol/water (45/45/10 v/v/v). The
gradient programme allowed for 1.9 min at 0% B, followed by
an 18.1 min step that raised eluent B to 57%. Subsequent
washing at 100% B and equilibration at 0% B was performed
in a total analysis time of 26 min. Amino acids in the
lipopeptide hydrolysis products were identified based on
amino acid standards analysed simultaneously.
Accurate mass measurements and structural
identification by FT-ICR mass spectrometry
Prior to further analysis, CLP fractions separated by semi-
preparative HPLC were submitted to supplementary desalt-
ing via nanochromatography (Ultimate LC system, Dionex,
LC-Packings, Amsterdam, the Netherlands). Starting from a
volume of 1 μl of CLP fractions, peptides were desalted
using a Pepmap C18 column (15 cm × 75 μm; Thermo Sci-
entific) at 200 nl min−1 solvent flow. Elution was performed
with gradients of solvent A (95% H2O, 5% ACN and 0.1%
HCOOH) and solvent B (25% H2O, 75% ACN and 0.1%
HCOOH): 6 min in 100% solvent A, then solvent B was
increased to 50% over 15 min, kept at 50% during 10 min,
then solvent B was increased to 75% over 10 min, and to
100% over 5 min during 15 min. Finally, solvent B was
decreased to 0% in 5 min. The column was allowed to equili-
brate for 15 min. The fractions containing sessilin and
orfamide were collected during 100% B elution. Subse-
quently, samples were concentrated six times before analy-
sis and placed in 75% ACN solution acidified with 0.1%
formic acid. The analyses were performed using an Apex Qe
9.4 T Fourier Transform Ion Cyclotron Resonance mass
spectrometer (Bruker Daltonics, Bremen, Germany). The
FT-ICR mass spectrometer was equipped with a nano-
electrospray source. Detection was carried out in positive
mode. A potential of 1.6 kV was applied to the needle
(PicoTip Emitter, New Objective, Woburn, MA, USA). Detec-
tion parameters were as follows: broadband detection, 512 K
acquisition size, start mass at m/z 500 for MS spectra and
200 for ECD spectra. Ions were accumulated in the storage
hexapole during 1 s and in the second hexapole during
0.01 s. Parameters used for ECD experiments were ECD
pulse 0.03 s, bias 2.0 V, heater 20 V and cathode current
1.5 A. Spectra were manually processed using DATAANALYSIS
software (Bruker Daltonics, Bremen, Germany).
Sequencing and analysis of CMR12a CLP
biosynthesis genes
Whole-genome sequencing of a genomic DNA sample of
CMR12a was performed with a Genome Sequencer FLX
(Roche 454) by NXTGNT (Gent, Belgium). Draft genome
assemblies were achieved with two de novo assemblers,
namely MIRA (Chevreux et al., 1999) and VELVET (Zerbino and
Birney, 2008). Preliminary structural analysis results showed
that CMR12a produces two distinct lipopeptides, most
resembling orfamide from P. protegens Pf-5 and tolaasin from
P. tolaasii respectively (D’aes et al., 2011). Syringopeptin is
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the CLP most related to tolaasin for which the biosynthesis
gene cluster has been sequenced completely. Therefore, the
genome alignment program MAUVE (Darling et al., 2004) was
used to order the contigs from the MIRA CMR12a draft
genome according to the P. protegens Pf-5 (Paulsen et al.,
2006) and P. syringae pv. syringae B728a (Feil et al., 2005)
genomes. Putative NRPS clusters derived this way were
subsequently completed and validated by identification of
contig overlaps and comparison with the Velvet assembly.
Additional Sanger sequencing (LGC Genomics) was per-
formed to resolve ambiguous nucleotides and fill small gaps.
Putative ORFs were identified with GLIMMER (Delcher et al.,
2007). The resulting putative protein sequences were ana-
lysed with online NRPS specificity prediction software,
namely ‘NRPSPREDICTOR’ (Rausch et al., 2005). Sequence
similarity analysis and gene annotation of NRPS ORFs
and flanking genes was performed by BLASTX analysis on
NCBI.
Phylogenetic analysis of C domains
The sequences of all C domains were analysed to distin-
guish between domains harbouring conventional C activity
(C domains) and those displaying dual CE activity (dual C/E
domains) (Roongsawang et al., 2005; Rausch et al., 2007).
The protein sequences corresponding to these domains
were extracted using the PKS/NRPS analysis tool
(Bachmann and Ravel, 2009) and aligned with related
sequences found in known CLP synthetases. NRPSs
responsible for the synthesis of arthrofactin (ArfA, ArfB and
ArfC) (Balibar et al., 2005), massetolide (MassA, MassB
and MassC) (De Bruijn et al., 2008), orfamide (OfaA, OfaB
and OfaC) (Gross et al., 2007), syringopeptin 22A (SypA,
SypB and SypC) (Scholz-Schroeder et al., 2003) and
syringomycin (SyrE) (Singh et al., 2007) were included in
the analysis. One supplementary synthetase for putisolvin
(PsoA, PsoB and PsoC) was considered, although the
D-monomers present in the published peptide sequences
were deduced from predictive analysis and not yet experi-
mentally confirmed (Dubern et al., 2008).
Construction of pMQ30-ΔCLP2 and mutagenesis
of CMR12a
To construct mutants CMR12a-ΔCLP2 and CMR12a-ΔPhz-
ΔCLP2, a large (8 kb) fragment of the CLP2 biosynthesis
genes was deleted by allelic replacement with vector pMQ30
(Hoang et al., 1998; Shanks et al., 2006). Two coding
regions, located approximately in the middle of ofaB and ofaC
of CMR12a, were amplified with primers CLP2-Up-F and
CLP2-Up-R (1003 bp) and primers CLP2-Down-F and CLP2-
Down-R (989 bp) respectively. These two polymerase chain
reaction (PCR) products were cloned next to each other via in
vivo homologous recombination in the yeast S. cerevisiae
InvSc1, resulting in deletion plasmid pMQ30-ΔCLP2. This
plasmid was mobilized into CMR12a and CMR12a-ΔPhz
by conjugation with E. coli BW29427 and selection on
gentamycin. Next, transconjugants that had lost the plasmid
during a second crossover event were selected on 10%
sucrose, whereupon the deletion was confirmed by PCR.
Finally, the two resulting mutants were subjected to another
round of mutagenesis with pEX18Tc-CLP1, as described by
D’aes and colleagues (2011), to obtain CMR12a-ΔCLP2-
CLP1 and CMR12a-ΔPhz-ΔCLP2-CLP1.
Analysis of phenazine and CLP production by CMR12a
biosynthesis mutants
The presence of phenazines in a culture extract was
determined by thin-layer chromatography and HPLC
(Perneel et al., 2007). Spectrophotometric measurements
on a cell-free culture supernatant (λ = 369 nm and ε =
11 393 M−1 cm−1) provided quantitative data for phenazine
production.
Production of CLPs was first tested qualitatively by the drop
collapse technique (Jain et al., 1991). In addition, surface
tension of a cell-free culture supernatant was measured with
the Wilhelmy plate method, as described by Perneel and
colleagues (2007) with minor modifications. For LC-ESI-MS
analysis, supernatant samples were collected after 72 h of
growth on KB medium and subjected to reverse phase
LC-ESI-MS as described above.
Swarming motility assays
Swarming motility of CMR12a and its mutants was tested on
MLB medium (contains 40% of the nutrients of LB) and SSM
(De Bruijn et al., 2008) with 0.6% agar. Cultures were grown
during 16 h in LB broth and washed twice with saline solution
(0.85%). Five microlitres of the suspensions was spotted in
the centre of the plates and incubated at 28°C for 24 h (MLB
medium) or 48 h (SSM). For complementation assays, the
two bacterial suspensions were mixed in equal volumes, and
5 μl of the mixture was spotted. At least three replicates per
strain were included, and the experiments were repeated at
least twice.
Biofilm formation assays
Development of biofilms in polystyrene 96-well plates was
tested according to a method adapted from Maddula and
colleagues (2006) and Merrit and colleagues (2005). Wells of
a polystyrene 96-well flat bottom microtiter plate were filled
with 120 μl AB minimal medium amended with 2% casamino
acids (CAA) (Schleif and Wensink, 1981) and inoculated with
1.2 μl of overnight bacterial cultures in LB broth, diluted to an
OD620 of 0.8. Per treatment, 11 replicates were included.
Plates were incubated at 28°C for up to 72 h, and develop-
ment of a biofilm at the air–liquid interface was assessed at
different time points. For each time point, OD620 of a plate was
measured, after which unbound cells and medium were
removed by thoroughly rinsing with tap water. To colour the
attached cells, 150 μl of 0.1% crystal violet solution in water
was added to each well, following incubation for 10 min at
room temperature. Unbound crystal violet was removed by
immersing the plates twice in tap water, and 200 μl of 95%
ethanol was added to the wells to re-dissolve the cell-bound
crystal violet. Subsequently, 120 μl of the crystal violet solu-
tion in 95% ethanol was transferred to a new 96-well plate,
and the optical density was measured at 595 nm. Experi-
ments were repeated at least twice. For statistical data analy-
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sis, non-parametric Kruskal–Wallis and Mann–Whitney
U-tests (α = 0.05) were performed.
Analysis of sessilin and orfamide production under
biofilm or swarming conditions
All cells were scraped from the swarming plates and diluted in
6 ml ACN/water 50/50 v/v. The mixture was ultrasonicated for
2 min, centrifuged at 14 000 r.p.m. during 20 min and then
1 ml was injected in LC-ESI-MS for analysis.
Production of CLPs under conditions of biofilm formation in
96-well plates was measured directly in the liquid material
collected and pooled from 15 wells. The resulting sample was
centrifuged at 14 000 r.p.m. for 10 min and injected as such
in LC-ESI-MS for analysis.
White-line-in-agar assay
The white-line-in-agar test was performed in triplicate on KB
(Rokni-Zadeh et al., 2012). Cultures were grown during 16 h
in LB broth and washed twice with saline solution (0.85%).
The line of bacterial strains in the middle of the plates was
made from three drops (5 μl drop−1) of the suspension. After
that, 5 μl of each bacterial strain suspension was spotted at
both sides of the line with 1 cm distance. White precipitate
formation in the agar was evaluated after 6 days of growth
at 28°C.
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Supporting information
Additional Supporting Information may be found in the online
version of this article at the publisher’s web-site:
Fig. S1. Chromatogram of HPLC analysis of acid hydroly-
sate of sessilin A. Amino acid peaks were assigned based on
amino acid standards, and relative amounts of each amino
acid present in the hydrolysate were calculated based
on standard curves obtained for each amino acid standard.
Glx, glutamine or glutamate; Ser, serine; Hse, homoserine;
dhAbu, 2,3-dehydro-2-aminobutyric acid; aThr, allothreonine;
Val, valine; Ile, isoleucine; Leu, leucine; Lys, lysine; Dab,
2,4-diaminobutyric acid; Pro, proline.
Fig. S2. Chromatogram of HPLC analysis of acid hydroly-
sate of orfamide E. Amino acid peaks were assigned based
on amino acid standards, and relative amounts of each amino
acid present in the hydrolysate were calculated based on
standard curves obtained for each amino acid standard. Glx,
glutamine or glutamate; Ser, serine; aThr, allothreonine; Val,
valine; Leu, leucine.
Fig. S3. High-resolution spectra of sessilin A. (A) NanoESI-
Qh-FT-ICR MS spectrum showing the isotopic pattern of the
doubly charged sessilin A C96H168O25N22 (Δm = 1.08 p.p.m. on
monoisotopic peak, Δm = 0.01 p.p.m. on more abundant iso-
topic peak); the peaks annotated with asterisk are issued
from a second doubly charged pattern corresponding to
C96H166O25N22, (Δm = 0.88 p.p.m. on monoisotopic peak,
Δm = 0.98 p.p.m. on more abundant isotopic peak). (B) Theo-
retical spectrum of the doubly charged species C96H168O25N22
C. Theoretical spectrum of the doubly charged species
C96H166O25N22.
Fig. S4. NanoESI-Qh-FT-ICR ECD spectrum of sessilin A
(C96H168O25N22). Details related to ion molecular formulae and
Δm are presented in Supporting Information Table S1. dhAbu,
2,3-dehydro-2-aminobutyric acid; Pro, proline; Ser, serine;
Leu, leucine; Val, valine; Gln, glutamine; Leu, leucine; Thr,
threonine; Ile, isoleucine; Hse, homoserine; Dab, 2,4-
diaminobutyric acid; Lys, lysine.
Fig. S5. NanoESI-Qh-FT-ICR ECD spectrum of orfamide E
(C63H112O17N10). Details related to ion molecular formulae and
Δm are presented in Supporting Information Table S2. Leu,
leucine; Glu, glutamate; Thr, threonine; Val, valine; Ser,
serine.
Fig. S6. Phylogenetic tree constructed for condensation
domains extracted from synthetases for syringopeptin (SypA,
SypB and SypC) and syringomycin (SyrE) from P. syringae
pv. syringae B301D, arthrofactin (ArfA, ArfB and ArfC) from
Pseudomonas sp. MIS38, putisolvin (PsoA, PsoB and PsoC)
from P. putida PCL1445, massetolide (MassA, MassB and
MassC) from P. fluorescens SS101, orfamide (OfaA, OfaB
and OfaC) from P. fluorescens Pf-5 and sessilin (SesA,
SesB and SesC) and orfamide (designated as OfaA-12a,
OfaB-12a and OfaC-12a to avoid confusion with OfaA, OfaB
and OfaC from P. fluorescens Pf-5). Black and white arrows
indicate sessilin C domains and orfamide C domains respec-
tively. C domain, condensation domain; dual C/E domain,
dual condensation/epimerization domain.
Fig. S7. ESI-MS spectra presenting analysis of sessilin and
orfamide production by Pseudomonas CMR12a and the new
sessilin (Clp1) and orfamide (Clp2) mutants that were con-
structed in this study. y-Axis represents relative intensity.
ΔPhz, mutation in phenazine biosynthesis.
Fig. S8. Swarming ability of CMR12a and CLP mutants on
soft MLB medium or soft MLB medium supplied with a semi-
purified orfamide extract. Semi-purified orfamide extract was
obtained from a culture of Pseudomonas CMR5c (a biocon-
trol strain that only produces orfamide, not sessilin, and
readily releases orfamide in the medium) in KB medium by
acidifying the supernatant with ethyl acetate, centrifugation
and further extraction with methanol. After evaporation, the
semi-purified orfamide extract was redissolved in ethanol.
Orfamide was supplied at a final concentration of 4 μg ml−1
medium. Control plates were supplied with ethanol only. Bac-
terial cultures were grown during 16 h in LB broth and
washed twice with saline solution (0.85%). Five microlitres
of the suspensions was spotted in the centre, and plates
were incubated at 28°C for 24 h or 48 h. CMR12a, wild-
type Pseudomonas CMR12a; CMR12a-Clp1, sessilin
biosynthesis mutant; CMR12a-ΔClp2, orfamide biosynthesis
mutant; CMR12a-ΔClp2-Clp1, orfamide and sessilin double
mutant.
Fig. S9. Swarming ability of CMR12a and CLP mutants on
soft MLB medium or soft MLB medium supplied with super-
natant from orfamide or sessilin-producing strains. To
produce supernatants, CMR12a-Clp1 (produces orfamide),
CMR12a-ΔClp2 (produces sessilin) and CMR12a-ΔClp2-
Clp1 (negative control) were grown overnight in 50 ml LB at
28°C. The supernatant was centrifuged to remove cells and
filter sterilized. MLB medium was supplemented with 30%
supernatant from each strain. Control media were supplied
with 0%, 20% and 30% LB medium. A control with 20% LB
medium was included because the bacteria will have used
part of the nutrients in the LB medium. The final agar con-
centration was always 0.6%. For inoculation, CMR12a and
CLP mutants were grown during 16 h in LB broth and
washed twice with saline solution (0.85%). Five microlitres
of the suspensions was spotted in the centre, and plates
were incubated at 28°C for 24 h and 48 h. The orfamide-
containing supernatant complements swarming in the
orfamide-negative mutants; the sessilin-containing superna-
tant hampers swarming in the wild-type strain CMR12a,
but not in the sessilin-negative Clp1 mutant. CMR12a,
wild-type Pseudomonas CMR12a; CMR12a-Clp1, sessilin
biosynthesis mutant; CMR12a-ΔClp2, orfamide biosynthesis
mutant; CMR12a-ΔClp2-Clp1, orfamide and sessilin double
mutant.
Fig. S10. Analysis of white line by MALDI-ToF mass spec-
trometry. Left: schematic representation of white line forma-
tion during the interaction among the CMR12a-ΔClp2 mutant
(middle), the CMR12a-Clp1 mutant (bottom) and CMR12a-
ΔClp2-Clp1 mutant (top). Red circles represent the locations
of medium sampling close to CMR12a-ΔClp2, close to
CMR12a-Clp1 and in the white line. Right: typical molecular
ions (m/z for [M + H]+ or [M + Na]+*, n.d., not detected) corre-
sponding to the three sessilins (S-A, S-B and S-C) and
orfamides (Ofa-D, Ofa-E and Ofa-B) detected by MALDI-ToF
in the plugs sampled from the KB agar medium at the loca-
tions indicated.
Table S1. Mass measurement errors on molecular and frag-
ment ions resulting from sessilin A nanoESI-Qh-FT-ICR MS
ECD experiments (Fig. 3).
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Table S2. Mass measurement errors on molecular and frag-
ment ions resulting from orfamide E nanoESI-Qh-FT-ICR MS
ECD experiments (Fig. 4).
Table S3. Strains, plasmids and primers used in this study.
Primer extensions are in italic font. *PHZ, phenazines; CLP,
cyclic lipopeptide; CLP1, sessilin; CLP2, orfamide; GmR,
TcR, AmpR, KmR, resistant to gentamycin, tetracyclin, ampi-
cillin, kanamycin respectively; BCCM, Belgian Co-ordinated
Collections of Microorganisms.
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